We are live on ! Find out more
LAB icon

Standard BioTools

160 hedge funds and large institutions have $337M invested in Standard BioTools in 2025 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 47 increasing their positions, 45 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

142% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 12

39% more call options, than puts

Call options by funds: $68K | Put options by funds: $49K

10% more funds holding

Funds holding: 145160 (+15)

9% more capital invested

Capital invested by funds: $308M → $337M (+$29M)

4% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 45

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

1.29% less ownership

Funds ownership: 75.16%73.87% (-1.3%)

Holders
160
Holders Change
+15
Holders Change %
+10.34%
% of All Funds
2.11%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
29
Increased
47
Reduced
45
Closed
12
Calls
$68K
Puts
$49K
Net Calls
+$19K
Net Calls Change
+$75K
Name Holding Trade Value Shares
Change
Change in
Stake
California State Teachers Retirement System (CalSTRS)
51
California State Teachers Retirement System (CalSTRS)
California
$230K -$23.7K -21,368 -10%
MIM
52
MetLife Investment Management
New Jersey
$218K +$66.8K +60,285 +50%
Invesco
53
Invesco
Georgia
$216K -$1.96K -1,765 -1%
Mirae Asset Global ETFs Holdings
54
Mirae Asset Global ETFs Holdings
Hong Kong
$197K -$13.7K -12,355 -7%
IIM
55
INTECH Investment Management
Florida
$179K +$9.44K +8,519 +6%
JP Morgan Chase
56
JP Morgan Chase
New York
$173K -$1.95K -1,756 -1%
Bank of America
57
Bank of America
North Carolina
$165K -$8.61K -7,768 -5%
Janus Henderson Group
58
Janus Henderson Group
United Kingdom
$157K
Citigroup
59
Citigroup
New York
$154K -$107K -96,571 -43%
EWM
60
Evercore Wealth Management
New York
$150K
FSCM
61
Front Street Capital Management
Montana
$145K +$134K +120,525 New
Manulife (Manufacturers Life Insurance)
62
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$138K +$8.39K +7,570 +7%
XT
63
XTX Topco
Cayman Islands
$116K -$68.3K -61,596 -39%
VOYA Investment Management
64
VOYA Investment Management
Georgia
$105K +$887 +800 +0.9%
OC
65
Oppenheimer & Co
New York
$104K
Balyasny Asset Management
66
Balyasny Asset Management
Illinois
$103K
QC
67
Quadrature Capital
United Kingdom
$101K +$59.7K +53,852 +178%
WC
68
Wexford Capital
Florida
$100K
New York State Common Retirement Fund
69
New York State Common Retirement Fund
New York
$94.8K
PAS
70
Point72 Asia (Singapore)
Singapore
$86K +$79.5K +71,690 New
ASRS
71
Arizona State Retirement System
Arizona
$85.5K +$8.29K +7,483 +12%
SEI Investments
72
SEI Investments
Pennsylvania
$78.8K +$2.28K +2,055 +3%
ProShare Advisors
73
ProShare Advisors
Maryland
$73.7K -$2.75K -2,479 -4%
Creative Planning
74
Creative Planning
Kansas
$73.3K +$24.5K +22,082 +57%
PFSRSONJ
75
Police & Firemen's Retirement System of New Jersey
New Jersey
$72.8K

LAB Hedge Fund Activity: Q2 2025 in Review

160 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q2 2025, worth a combined $337M — up 9.4% from $308M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new LAB positions and 12 closed out — a net gain of 17 holders — while 47 added to existing stakes and 45 trimmed.

The largest buyer was Long Focus Capital Management, adding an estimated $3.74M. The largest seller was Morgan Stanley, cutting an estimated $4.97M.

  • 160 institutional investors held Standard BioTools (LAB) as of Q2 2025, up from 145 in Q1 2025.
  • Funds reported $337M of Standard BioTools stock for Q2 2025, up 9.4% quarter-over-quarter.
  • 29 funds opened new Standard BioTools positions in Q2 2025 and 12 closed out, a net change of +17 holders.
  • The largest Standard BioTools buyer in Q2 2025 was Long Focus Capital Management, an estimated $3.74M added.
  • The largest Standard BioTools seller in Q2 2025 was Morgan Stanley, an estimated $4.97M sold.

Based on aggregated 13F filings for Q2 2025.